Novel β‑amyloid PET Imaging Study of [18F]92 in Patients with Cognitive Decline
Ming Ni,
Xingxing Zhu,
Kaixuan Wang,
Wenliang Guo,
Qin Shi,
Yuying Li,
Mengchao Cui,
Qiang Xie
Affiliations
Ming Ni
Department of Nuclear Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
Xingxing Zhu
Department of Nuclear Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
Kaixuan Wang
Department of Nuclear Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
Wenliang Guo
Department of Neurology, the Second Hospital of Anhui Medical University, Hefei, Anhui, China
Qin Shi
Department of Nuclear Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
Yuying Li
Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, China
Mengchao Cui
Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, China
Qiang Xie
Department of Nuclear Medicine, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China